Anaemia drugs poser
THERE is not enough data to prove widely used anaemia drugs to improve outcomes for kidney patients who undergo organ transplantation, a US Medicare advisory panel said this week.
Advisers to the agency said there are not enough available studies to show using the drugs to boost patients' haemoglobin levels can help patients have a more successful kidney transplant.
Would you like to comment on this article or view other readers' comments? Register (it’s quick and free) or sign in now.
Please read our Comment Policy before commenting.